CombinatoRx, Inc. (CRXX)
A biopharmaceutical company pioneering the new field of synergistic combination pharmaceuticals, with a portfolio of product candidates in phase 2 clinical development.
Recs
Recs
CRXX has a great pipeline and plenty of cash. Just a matter of time untill one of it's many phase II drugs is approved and a partner moves in. Buy now before it.s to late!
Recs
Another small-cap biotech knocked down to an all-time low in the absence of clear negative catalysts. Their pipeline appears to be proceeding well with encouraging phase II data for CRx-191 in psoriasis, and several other phase II trials in progress. The generic combo concept seems a little bargain basement, but the upside potential of new treatments for common diseases such as arthritis and diabetes cannot be ignored - witness the mad overreaction Rigel got with phase II data. Financials also appear strong with cash position more than 100M and a manageable burn. Eeventually this worm will turn and beaten down baby biotechs will recover.
Recs
stratton6 @ 4.94
Recs
Recently saw one of their presentations. Seems like they have a reasonable platform that is highly partnerable.
Recs
6 drugs in phase 2 ...time to get it is now...
Recs
Very strong pipeline currently not priced in. High degree of probability for approvals based on test results so far, but approvals still a ways out.
Recs
Taking a flyer on a young research pharm company. Solid management, cutting edge techology/research. Like all early pharms has risk but I think this one has huge upside.
Recs
Look for a double
Recs
Picked by patelketan

RSS Headlines
Fool UK
- Show Me:
-
Outperform
-
Underperform
-
All
- Sort by:
-
Author
-
Recs
-
Date
-
Member Rating
-
Results 1 - 10 of 10